Zevalin
Links shared publicly online about this topic
ZEVALIN® (ibritumomab tiuxetan) - Targeted. Proven. Today.
zevalin.com — “ZEVALIN (ibritumomab tiuxetan) from Spectrum Pharmaceuticals is a CD20-directed radiotherapeutic antibody.” View full resource at zevalin.com
Most Recently Shared on November 21, 2011 at 10:02 pm By:
Kristin Gustafson Patient Advocate and Health Business Administrator
FDA removes bioscan requirements from Zevalin http://t.co/DKkvbkNd
FDA Removes Bioscan Requirement for Zevalin - MPR
empr.com — “Spectrum announced that the FDA has approved the removal of the pre-treatment biodistribution evaluation requirement using Indium-111 Zevalin (radionuclide [B-lymphocyte-restricted differentiation antigen (CD20) inhibitor]) imaging dose followed by a gamma scan before administering the Zevalin therapeutic dose.” View full resource at empr.com
Most Recently Shared on November 21, 2011 at 2:28 pm By:
FDA Removes Bioscan Requirement for Zevalin http://t.co/yNwKV12U #lymphoma
Zevalin Active for Treatment of Extranodal Marginal-zone Lymphoma
professional.cancerconsultants.com — “Zevalin Active for Treatment of Extranodal Marginal-zone Lymphoma” View full resource at professional.cancerconsultants.com
Most Recently Shared on October 6, 2009 at 8:54 pm By:
Zevalin® Active for Treatment of Extranodal Marginal-zone #Lymphoma http://bit.ly/63o6Y
Zevalin Consolidation Increases Molecular Remission in Patients with Follicular Lymphoma
professional.cancerconsultants.com — “Zevalin Consolidation Increases Molecular Remission in Patients with Follicular Lymphoma” View full resource at professional.cancerconsultants.com
Most Recently Shared on December 30, 2009 at 5:06 pm By:
Zevalin RIT consolidation gave 87% of Follicular pts complete response & longer PFS compared to 51% w/out. http://bit.ly/5ZMVgr
Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA
news-medical.net — “Spectrum Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Prior Approval Supplement containing data providing for the removal of the Indium-111 ZEVALIN® (ibritumomab tiuxetan) pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.” View full resource at news-medical.net
Most Recently Shared on March 23, 2011 at 7:55 am By:
News-Medical.Net Oncology and Health News
Oncology News: Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA: Spectrum ... http://bit.ly/fsrqm5
Spectrum announces various clinical studies on ZEVALIN at ICML 2011
news-medical.net — “Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that various studies on ZEVALIN for Injection were presented at the 11th International Conference on Malignant Lymphoma (ICML), held June 15-18, 2011, in Lugano, Switzerland.” View full resource at news-medical.net
Most Recently Shared on June 20, 2011 at 2:32 pm By:
News-Medical.Net Oncology and Health News
Oncology News: Spectrum announces various clinical studies on ZEVALIN at ICML 2011: Spectrum Pharmaceuticals, a ... http://bit.ly/m0fcSV
Spectrum Pharma Provides FDA With Addl. Details For Cancer Drug Zevalin - Update
rttnews.com — “RTTNews delivers all the important global financial news, stock alerts, Market analysis, breaking news and any news that may impact individual stocks,specific commodities, currencies and markets as a whole” View full resource at rttnews.com
Most Recently Shared on August 1, 2009 at 12:44 pm By:
FDA's decision to approve Zevalin as first-line consolidation therapy for NHL expected 09/08/09. http://bit.ly/6y1Ca http://bit.ly/15Njm2
Spectrum Pharmaceuticals Submits Data To FDA In Support Of Bioscan Removal For ZEVALIN(R)
medicalnewstoday.com — “Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced that on Thursday, J” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2011 at 2:05 pm By:
Spectrum Pharmaceuticals Submits Data To FDA In Support Of Bioscan Removal For ZEVALIN(R) http://mnt.to/3QrR #lymphoma #leukemia
StreetInsider.com - Spectrum Pharma (SPPI) Announces FDA Approval of ZEVALIN(R) Expanded Label
streetinsider.com — “StreetInsider.com - Spectrum Pharma (SPPI) Announces FDA Approval of ZEVALIN(R) Expanded Label” View full resource at streetinsider.com
Most Recently Shared on September 4, 2009 at 5:09 pm By:
Once again, Zevalin has won FDA approval as a first line consolidation therapy for lymphoma. http://bit.ly/zTAoa
‘Disruptive’ radiation oncologist sees a win as Zevalin gets approval « MedCity News
medcitynews.com — “‘Disruptive’ radiation oncologist sees a win as Zevalin gets approval « MedCity News” View full resource at medcitynews.com
Most Recently Shared on September 5, 2009 at 4:28 am By:
Radioimmunotherapy is "a classic disruptive technology that's a disadvantage to the status quo." Zevalin expansion=win. http://bit.ly/s7zlw
StreetInsider.com - Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN®
streetinsider.com — “StreetInsider.com - Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN®” View full resource at streetinsider.com
Most Recently Shared on January 25, 2011 at 12:03 am By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN® http://ow.ly/3Ju0q
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - ONA
oncologynurseadvisor.com — “Spectrum Pharmaceuticals announced results from both a Phase 2 and Phase 3 study of Zevalin (ibritumomab tiuxetan) injection for the treatment of follicular non-Hodgkin's lymphoma (NHL).” View full resource at oncologynurseadvisor.com
Most Recently Shared on December 7, 2010 at 8:49 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) http://goo.gl/fb/I2Tif
Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL) - MPR
empr.com — “Spectrum Pharmaceuticals announced results from both a Phase 2 and Phase 3 study of Zevalin (ibritumomab tiuxetan) injection for the treatment of follicular non-Hodgkin's lymphoma (NHL).” View full resource at empr.com
Most Recently Shared on December 7, 2010 at 9:12 pm By:
MPR News: Phase 2 and 3 studies of Zevalin for the treatment of non-Hodgkin's lymphoma (NHL): Spectrum Pharmaceu... http://bit.ly/hPNeyO
Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin's Lymphoma
news-medical.net — “Spectrum Pharmaceuticals (NasdaqGM:SPPI), a commercial-stage biotechnology company with a focus in oncology, today announced ZEVALIN® (ibritumomab tiuxetan), a CD20-directed radiotherapeutic antibody, received approval from the U.S. Food and Drug Administration (FDA) for an expanded label for the treatment of patients with previously untreated follicular non-Hodgkin's Lymphoma (NHL), who achieve a partial or complete response to first-line chemotherapy.” View full resource at news-medical.net
Most Recently Shared on September 5, 2009 at 6:57 am By:
Medicare News: Spectrum's ZEVALIN expanded label receives FDA approval for treating non-Hodgkin’s .. http://digg.com/u1C1sH
Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009
news-medical.net — “Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the fourth quarter and fiscal year ended December 31, 2009.” View full resource at news-medical.net
Most Recently Shared on April 5, 2010 at 11:18 am By:
Spectrum Pharmaceuticals reports $15.7M revenue from ZEVALIN sales in 2009: Spectrum Pharmaceuticals, Inc., a comm... http://bit.ly/bj3Y4Z
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Kristin Gustafson
A resource dedicated to the education of chemotherapy patients.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
Lymphomation.org
Lymphomation.org/Patients Against Lymphoma -- Providing support and timely access to evidence-based information on lymphomas and their treatment.
Advertisement
